scispace - formally typeset
C

Carlos A. Aguilar-Salinas

Researcher at Monterrey Institute of Technology and Higher Education

Publications -  288
Citations -  10876

Carlos A. Aguilar-Salinas is an academic researcher from Monterrey Institute of Technology and Higher Education. The author has contributed to research in topics: Population & Type 2 diabetes. The author has an hindex of 50, co-authored 286 publications receiving 7325 citations. Previous affiliations of Carlos A. Aguilar-Salinas include Yahoo!.

Papers
More filters
Journal ArticleDOI

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

Bin Zhou, +1144 more
- 11 Sep 2021 - 
TL;DR: In this article, a Bayesian hierarchical model was used to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control).
Journal ArticleDOI

Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.

TL;DR: A mechanistic approach to evaluate risk for complications and lethality attributable to COVID-19 considering the effect of obesity and diabetes in Mexico is proposed and offers a clinical tool for quick determination of high-risk susceptibility patients in a first contact scenario.
Journal ArticleDOI

Transancestral mapping and genetic load in systemic lupus erythematosus

Carl D. Langefeld, +116 more
TL;DR: A large transancestral association study of SLE using Immunochip genotype data from 27,574 individuals of European, African and Hispanic Amerindian ancestry identifies both ancestry-dependent and ancestry-independent contributions to SLE risk.
Journal ArticleDOI

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society

TL;DR: In this paper, a conceptual framework for the generation of remnants due to dysregulation of TRL production, lipolysis, and remodelling, as well as clearance of remnant lipoproteins from the circulation, and challenges in defining, quantifying, and assessing the atherogenic properties of remnant particles.